Part 2 of 2 — Havas (Trent University): Aires Defender Infinity Improves Cardiovascular Response & Body Energy Balance
Double-Blind Case Study • Dr. Magda Havas, Trent University, Canada • August 20, 2015 • Subject: 46-year-old healthy female
Two-Study Series by Dr. Magda Havas
① Part 1 (Aug 18, 2015)
52-year-old female with EHS. Double-blind, placebo-controlled. Cardiovascular improvements and live blood (rouleaux) improvements confirmed with shield vs. placebo.
② This Study (Aug 20, 2015)
46-year-old healthy female. Replicates cardiovascular findings. Adds GDV Bio-Well energy measurements as supplementary data (non-mainstream tool — see note below).
Report title: “Case Study: Effect of Radio Frequency Radiation (RFR) and the Aires Defender Infinity on Endogenous Electromagnetic Energy of a 46-year old Healthy Female”
Report date: September 5, 2015 • Research conducted: August 20, 2015 • Second in a Series
Design: Double-blind (subject blindfolded, unaware of RFR source location or shield status)
Primary Findings (Validated Instruments)
Confirmed: Shield Did Not Change the RF Environment
The Defender Infinity did not alter RFR levels, ELF electric or magnetic fields, dirty electricity, or body current — consistent with manufacturer claims. Protective effects operated on the body’s endogenous EM response, not the external environment.
MaxPulse (FDA Class II): Cardiovascular Fully Restored with Shield
With RFR exposure, cardiovascular parameters deteriorated. Adding the shield reversed all deterioration and reached optimal levels:
• DPI (overall cardiovascular health): 80 (optimal) → 59 (normal, RFR) → 82 (optimal, RFR+shield)
• EC (eccentric constriction): 82 → 61 → 86 (optimal)
• AE (arterial elasticity): 80 → 66 → 84 (optimal)
• Mental stress: dropped from normal to low (favorable) with shield
• Stress resistance: increased from normal to high with shield
• Overall stress score: 51 → 37 when shield worn without RFR
These results replicate the cardiovascular pattern documented in Part 1 (52-year-old subject).
Orthostatic HRV (Nerve Express, FDA 510K): Minor Stress Response
HRV orthostatic testing showed a mild alarm reaction during RFR exposure (Treatment B) and some artifacts during RFR with shield (Treatment C). Subject had sufficient adrenal reserves to mount a response — contrasting with the exhausted adrenals seen in the Part 1 subject. HRV effects were minor; the cardiovascular MaxPulse data are the primary endpoint.
Supplementary Measurements (Non-Mainstream Tools)
GDV Bio-Well: Body Energy and Alignment (Supplementary)
Slight changes were noted in body energy field and energy balance with RFR exposure that reversed with shield plus RFR exposure. A blind GDV reviewer noted that the shield-only treatment (D) showed the most cohesive bio-field and best homeostasis scores. Chakra alignment showed misalignment during RFR that returned toward balance with the shield. As noted, these observations are from a non-medical, non-mainstream instrument and are presented as supplementary context only.
Conclusion (Author)
Dr. Havas concluded: “The Aires Defender Infinity does not alter the external (exogenous) electromagnetic environment, but it does alter the internal (endogenous) electromagnetic environment. The Aires Defender Infinity appears to have a beneficial effect on body energy balance, and both heart and blood vessel parameters.” The primary evidence base for this conclusion is the MaxPulse FDA Class II cardiovascular data.
About Dr. Magda Havas
Dr. Magda Havas is a professor at Trent University (Peterborough, Ontario, Canada) in Environmental and Resource Studies. She is one of Canada’s leading independent researchers on the biological effects of electromagnetic fields. This series represents independent Canadian academic research commissioned by American Aires Inc. for third-party validation.